[go: up one dir, main page]

GB0323109D0 - Novel compounds - Google Patents

Novel compounds

Info

Publication number
GB0323109D0
GB0323109D0 GB0323109A GB0323109A GB0323109D0 GB 0323109 D0 GB0323109 D0 GB 0323109D0 GB 0323109 A GB0323109 A GB 0323109A GB 0323109 A GB0323109 A GB 0323109A GB 0323109 D0 GB0323109 D0 GB 0323109D0
Authority
GB
United Kingdom
Prior art keywords
novel compounds
novel
compounds
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
GB0323109A
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Glaxo Group Ltd
Original Assignee
Glaxo Group Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Glaxo Group Ltd filed Critical Glaxo Group Ltd
Priority to GB0323109A priority Critical patent/GB0323109D0/en
Publication of GB0323109D0 publication Critical patent/GB0323109D0/en
Priority to CA002523431A priority patent/CA2523431A1/en
Priority to DK04728561T priority patent/DK1615909T3/en
Priority to EP04728561A priority patent/EP1615909B1/en
Priority to SI200430886T priority patent/SI1615909T1/en
Priority to MXPA05011352A priority patent/MXPA05011352A/en
Priority to HK06107421.8A priority patent/HK1090634B/en
Priority to BRPI0409611-8A priority patent/BRPI0409611A/en
Priority to RU2005136368/04A priority patent/RU2005136368A/en
Priority to PT04728561T priority patent/PT1615909E/en
Priority to AT04728561T priority patent/ATE402165T1/en
Priority to ES04728561T priority patent/ES2311152T3/en
Priority to PL04728561T priority patent/PL1615909T3/en
Priority to ARP040101348A priority patent/AR044045A1/en
Priority to DE602004015269T priority patent/DE602004015269D1/en
Priority to JP2006529693A priority patent/JP2006528939A/en
Priority to KR1020057019965A priority patent/KR20050121268A/en
Priority to PCT/EP2004/004245 priority patent/WO2004101546A1/en
Priority to TW093111027A priority patent/TW200503713A/en
Priority to US10/553,803 priority patent/US7592347B2/en
Priority to AU2004238447A priority patent/AU2004238447C1/en
Priority to HR20080541T priority patent/HRP20080541T3/en
Priority to MA28564A priority patent/MA27675A1/en
Priority to CO05106973A priority patent/CO5700754A2/en
Priority to IS8134A priority patent/IS8134A/en
Ceased legal-status Critical Current

Links

GB0323109A 2003-04-23 2003-10-02 Novel compounds Ceased GB0323109D0 (en)

Priority Applications (25)

Application Number Priority Date Filing Date Title
GB0323109A GB0323109D0 (en) 2003-10-02 2003-10-02 Novel compounds
HR20080541T HRP20080541T3 (en) 2003-04-23 2004-04-21 Piperazine derivatives and their use for the treatment of neurological and psychiatric diseases
PL04728561T PL1615909T3 (en) 2003-04-23 2004-04-21 Piperazine derivatives and their use for the treatment of neurological and psychiatric diseases
DE602004015269T DE602004015269D1 (en) 2003-04-23 2004-04-21 PIPERAZINE DERIVATIVES AND ITS USE IN THE TREATMENT OF NEUROLOGICAL AND PSYCHIATRIC DISEASES.
EP04728561A EP1615909B1 (en) 2003-04-23 2004-04-21 Piperazine derivatives and their use for the treatment of neurological and psychiatric diseases
SI200430886T SI1615909T1 (en) 2003-04-23 2004-04-21 Piperazine derivatives and their use for the treatment of neurological and psychiatric diseases
MXPA05011352A MXPA05011352A (en) 2003-04-23 2004-04-21 Piperazine derivatives and their use for the treatment of neurological and psychiatric diseases.
HK06107421.8A HK1090634B (en) 2003-04-23 2004-04-21 Piperazine derivatives and their use for the treatment of neurological and psychiatric diseases
BRPI0409611-8A BRPI0409611A (en) 2003-04-23 2004-04-21 piperazine derivatives and their use for the treatment of neurological and psychiatric disorders
RU2005136368/04A RU2005136368A (en) 2003-04-23 2004-04-21 PIPERASIN DERIVATIVES AND THEIR APPLICATION FOR TREATMENT OF NEUROLOGICAL AND PSYCHIATRIC DISEASES
PT04728561T PT1615909E (en) 2003-04-23 2004-04-21 Piperazine derivatives and their use for the treatment of neurological and psychiatric diseases
AT04728561T ATE402165T1 (en) 2003-04-23 2004-04-21 PIPERAZINE DERIVATIVES AND THEIR USE FOR THE TREATMENT OF NEUROLOGICAL AND PSYCHIATRIC DISEASES.
ES04728561T ES2311152T3 (en) 2003-04-23 2004-04-21 DERIVATIVES OF PIPERAZINE AND ITS USE FOR THE TREATMENT OF NEUROLOGICAL AND PSYCHIATRIC DISEASES.
CA002523431A CA2523431A1 (en) 2003-04-23 2004-04-21 Piperazine derivatives and their use for the treatment of neurological and psychiatric diseases
ARP040101348A AR044045A1 (en) 2003-04-23 2004-04-21 COMPOSITE OF PIPERIDINCARBONILPIPERAZINA, PHARMACEUTICAL COMPOSITION THAT INCLUDES IT, ITS USE FOR THE PREPARATION OF A MEDICINAL PRODUCT AND PROCEDURE FOR PREPARATION
DK04728561T DK1615909T3 (en) 2003-04-23 2004-04-21 Piperazine derivatives and their use in the treatment of neurological and psychiatric disorders
JP2006529693A JP2006528939A (en) 2003-04-23 2004-04-21 Piperazine derivatives and their use for the treatment of neurological and psychiatric disorders
KR1020057019965A KR20050121268A (en) 2003-04-23 2004-04-21 Piperazine derivatives and their use for the treatment of neurological and psychiatric diseases
PCT/EP2004/004245 WO2004101546A1 (en) 2003-04-23 2004-04-21 Piperazine derivatives and their use for the treatment of neurological and psychiatric diseases
TW093111027A TW200503713A (en) 2003-04-23 2004-04-21 Novel compounds
US10/553,803 US7592347B2 (en) 2003-04-23 2004-04-21 Piperazine derivates and their use for the treatment of neurological and psychiatric diseases
AU2004238447A AU2004238447C1 (en) 2003-04-23 2004-04-21 Piperazine derivatives and their use for the treatment of neurological and psychiatric diseases
MA28564A MA27675A1 (en) 2003-04-23 2005-10-19 PIPERAZINE DERIVATIVES AND THEIR USE IN THE TREATMENT OF NEUROLOGICAL AND PSYCHIATRIC DISEASES
CO05106973A CO5700754A2 (en) 2003-04-23 2005-10-21 PIPERAZINE DERIVATIVES AND THEIR USE IN THE TREATMENT OF NEUROLOGICAL AND PSYCHIATRIC DISEASES
IS8134A IS8134A (en) 2003-04-23 2005-11-21 Piperazine derivatives and their use in the treatment of neurological and mental disorders

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB0323109A GB0323109D0 (en) 2003-10-02 2003-10-02 Novel compounds

Publications (1)

Publication Number Publication Date
GB0323109D0 true GB0323109D0 (en) 2003-11-05

Family

ID=29415389

Family Applications (1)

Application Number Title Priority Date Filing Date
GB0323109A Ceased GB0323109D0 (en) 2003-04-23 2003-10-02 Novel compounds

Country Status (1)

Country Link
GB (1) GB0323109D0 (en)

Similar Documents

Publication Publication Date Title
GB0308114D0 (en) Novel compounds
GB0305918D0 (en) Novel compounds
GB0308186D0 (en) Novel compounds
GB0308185D0 (en) Novel compounds
GB0304424D0 (en) Novel compounds
EP1596860A4 (en) Novel compounds
EP1648885A4 (en) Novel compounds
GB0305426D0 (en) Novel compounds
GB0302431D0 (en) Novel compounds
GB0304809D0 (en) Novel compounds
GB0302546D0 (en) Novel compounds
GB0304802D0 (en) Novel compounds
GB0305291D0 (en) Novel compounds
GB0301872D0 (en) Novel compounds
GB0301955D0 (en) Novel compounds
GB0301593D0 (en) Novel compounds
GB0301592D0 (en) Novel compounds
GB0302988D0 (en) Novel compounds
GB0303464D0 (en) Novel compounds
GB0303467D0 (en) Novel compounds
GB0304408D0 (en) Novel compounds
GB0301591D0 (en) Novel compounds
GB0323109D0 (en) Novel compounds
GB0304803D0 (en) Novel compounds
GB0301589D0 (en) Novel compounds

Legal Events

Date Code Title Description
AT Applications terminated before publication under section 16(1)